MolNFT v1 · #163253 · protein
Edds lyase variant D290M/Y320M with bound formate
6RXA · Argininosuccinate lyase: “Edds lyase variant D290M/Y320M with bound formate”. X-ray diffraction, 1 ligand (NA), 6 pockets (best druggability 0.53). MolNFT v1 #163253 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 6RXA
- Type
- protein
- Length
- 497 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Argininosuccinate lyase
- UniProt
- Q11KV9
- Ligands
- NA
- Pockets
- 6 · best druggability 0.53
Structure
x-ray diffraction · 1 distinct chain · 69% helix, 4% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Argininosuccinate lyase | protein | 497 | 69% helix, 4% strand | Q11KV9 |
Ligands and binding sites
- NA · Sodium ion · metal · 2 copies · chains A
- FMT · Formic acid · additive · 3 copies · chains A
- GOL · Glycerol · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
6 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 195 | 0.53 | 0.78 | 22 | empty |
| 2 | 72 | 0.40 | 0.79 | 17 | empty |
| 3 | 88 | 0.39 | 0.77 | 18 | empty |
| 4 | 56 | 0.32 | 0.76 | 16 | empty |
| 5 | 55 | 0.32 | 0.77 | 15 | empty |
Compared structures
- 6RXA · EDDS lyase variant D290M/Y320M with bound formate · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q11KV9
- Elsewhere: RCSB PDB 6RXA · PDBe 6RXA · UniProt Q11KV9
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.